No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

MD Orthopaedics Publishes Clubfoot Chronicles, One Parent’s Heartfelt and Personal Account of Life With a Clubfoot Child

Editor: What To Know

  • New parents can quickly be overwhelmed with the demands of weekly doctor’s visits, the heavy casts, implementing daily stretches, checking that the casts and boots fit properly and simply managing the care of a newborn, especially if there are other children at home.
  • This is arguably the most critical part of treatment, as non-compliance with the prescribed bracing protocol can lead to relapse of the clubfoot, but there is little information available to help uncertain parents manage this critical piece of their child’s care.
  • While the physician plays a key role in the manipulation and casting portion of treatment, up to 95% of clubfoot treatment is managed –.

MD Orthopaedics, manufacturer of the gold-standard Mitchell Ponseti® orthotic solutions for the treatment of clubfoot, announces publication of the new book Clubfoot Chronicles, written by Brand Ambassador Maureen Hoff.

Clubfoot Chronicles offers an honest and heartfelt look into the ups and downs of raising a clubfoot child. While the physician plays a key role in the manipulation and casting portion of treatment, up to 95% of clubfoot treatment is managed – at home – by the parents. New parents can quickly be overwhelmed with the demands of weekly doctor’s visits, the heavy casts, implementing daily stretches, checking that the casts and boots fit properly and simply managing the care of a newborn, especially if there are other children at home.

Upon hearing her daughter’s clubfoot diagnosis, Maureen set out to find out as much as she could about the clubfoot defect and treatment options. She spent hours on the computer, finding plenty of information about the casting phase, but very little about the bracing phase of treatment – also known as the boots-and-bar phase. This is arguably the most critical part of treatment, as non-compliance with the prescribed bracing protocol can lead to relapse of the clubfoot, but there is little information available to help uncertain parents manage this critical piece of their child’s care. It was this struggle to find the information and resources she was looking for that motivated Maureen to write the book, so that other clubfoot parents would not face the same difficulties.

Clubfoot Chronicles tells the story of Maureen’s personal struggles in caring for her child and the fear, anxiety, and stress she felt trying to manage her daughter’s care. With brutal honesty, Maureen shines a light on the many challenges clubfoot parents face and shares the many resources she uncovered that helped her cope. It is her hope that other clubfoot parents will benefit from her experiences, wisdom and research and have a smoother, easier clubfoot journey.

Maureen Hoff has her master’s degree in Marriage and Family Therapy and is passionate about clubfoot advocacy, specifically providing support and resources for other clubfoot parents. She is the mother of 3 smart and sassy girls, the last of which was born with bilateral clubfoot in 2018. Maureen recently became a Brand Ambassador for MD Orthopaedics and is working with them to create supportive content for other clubfoot parents.

Clubfoot is one of the most common musculoskeletal birth defects, affecting one out of every 100 babies born worldwide. The non-surgical Ponseti Method is the gold standard treatment, used to remedy approximately 95% of clubfoot cases worldwide. This Method is safer, less expensive, and more effective, using weekly manipulation and casting of the clubfoot to “train” it to the proper position. After the casting phase is complete, the child is fitted with an ankle-foot orthotic (AFO) to keep the manipulated foot in position. The AFO is worn for 23 hours a day for three months, then during nap and overnight sleep time for up to five years.

Clubfoot Chronicles is available in e-book format on Amazon:

The book is also available from Amazon in paperback:

The paperback will also be available at Home – MD Orthopaedics – (easyordershop.com) beginning in mid-July.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy